statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Processa Pharmaceuticals, Inc. (PCSA) has disclosed a new risk, in the Accounting & Financial Operations category. Processa Pharmaceuticals, Inc. c...

Processa Pharmaceuticals' Future in Jeopardy: A Dive into Its Financial Crisis and Industry Risks

HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Titoli in rialzo
Le azioni di Avalo Therapeutics (NASDAQ:AVTX) hanno guadagnato il 267,15% a 17,44 dollari durante la sessione after-market di mercoled .
Le azioni di Processa Pharma (NASDAQ:PCSA...

12 titoli sanitari in movimento, after-market del 27/03/2024

HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

Processa Pharmaceuticals (NASDAQ:PCSA  Get Free Report)s stock had its speculative buy rating restated by Benchmark in a research note issued on Wednesday, Benzinga...

Processa Pharmaceuticals (NASDAQ:PCSA) Stock Rating Reaffirmed by Benchmark

HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule...

Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA  Get Free Report) Director Justin W. Yorke acquired 8,000 shares of the companys stock in a transaction that occurred on Tuesday, January...

Insider Buying: Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Director Buys 8,000 Shares of Stock

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.

Volume	4,087.00
52-Wk High	$18.00
52-Wk Low	$1.40

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.18	--	--	N/A
Q4'23	-$1.60	--	--	N/A
Q3'23	-$0.10	--	--	N/A
Q2'23	-$0.15	--	--	N/A
Q1'23	-$0.28	--	--	N/A

PCSA Processa Pharmaceuticals Inc

About

Feed

News

Earnings

Fundamentals